NCT05579158已完成不适用
Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 337
- 试验地点
- 2
- 主要终点
- Change in hepatic steatosis (%)
研究概览
简要总结
In non-alcoholic fatty liver disease (NAFLD), it is established that calorie restriction is the most essential dietary modification. The time-restricted diet is successful lowering total calorie consumption and insulin resistance, and is anticipated to be beneficial for patients with NAFLD. Therefore, this study aims to conduct a prospective study to determine the effect of time-restricted diet via a mobile application on the amount of intrahepatic fat and 10-year cardiovascular disease risk in patients with NAFLD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Aged ≥ 19 years who are willing and able to complete all procedures
- •Hepatic steatosis by imaging (ultrasound, computed tomography, magnetic resonance imaging, and controlled attenuation parameter (≥260 dB/m))
排除标准
- •Body mass index (BMI) <23
- •Other causes of chronic liver disease (HBV, HCV), autoimmune diseases or chronic cholestatic liver disease
- •Medications which cause liver disease or secondary hepatic steatosis (Tamoxifen, systemic corticosteroids, methotrexate, tetracycline, estrogens, valproic acid, and statin (registration is possible if statin is delivered in a consistent dosage within 12 weeks)
- •Significant alcohol intake (>210g/week for men, >140g/week for women)
- •Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure > 200/120 mmHg)
- •Psychiatric illnesses which limit ability to exercise safely
- •Diagnosed with diabetes on medication or insulin
- •Participation in a weight-loss program within 12 weeks
- •MRI contraindications
结局指标
主要结局
Change in hepatic steatosis (%)
时间窗: 16 weeks
Change in hepatic steatosis (%) on Magnetic Resonance Imaging (MRI) Proton Density Fat fraction (PDFF) of the Liver
次要结局
- Change in urine microalbumin (mcg/min)(16 weeks)
- Change in liver fibrosis by liver stiffness (kPa)(16 weeks)
- Change in body muscle mass (kg)(16 weeks)
- Change in 10-year atherosclerotic cardiovascular disease (ASCVD) risk(16 weeks)
- Change in hemoglobin A1c level (%)(16 weeks)
- Change in insulin sensitivity(16 weeks)
- Change in body weight (kg)(16 weeks)
- Change in systolic blood pressure (mmHg)(16 weeks)
- Change in serum alanine aminotransferase level (IU/L)(16 weeks)
- Change in body weight (kg) at 12 months after the intervention(64 weeks)
- Change in liver fibrosis (kPa) by Magnetic Resonance Elastography (MRE)(16 weeks)
- Change in low-density lipoprotein level (mg/dL)(16 weeks)
- Change in body weight (kg) at 6 months after the intervention(40 weeks)
- Change in liver steatosis by controlled attenuation parameter (dB/m)(16 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Impact of Time-restricted Feeding in NAFLDFatty Liver, NonalcoholicFatty Liver DiseaseFatty LiverNCT05220956Johannes Gutenberg University Mainz100
已完成
不适用
The Effect of Time-restricted Eating on Liver MetabolismNAFLDNutritional and Metabolic DiseasesObesityNCT04997486University of California, Davis5
已完成
不适用
Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) StudyNonalcoholic Fatty LiverNonalcoholic SteatohepatitisNCT05309642Ewha Womans University Mokdong Hospital72
进行中（未招募）
不适用
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLDNAFLDNCT04861571University of Iowa20
已完成
不适用
Time Restricted Feeding on Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver DiseaseNCT03786523Nanfang Hospital, Southern Medical University88